Kawasaki disease in East Mazandaran, Islamic Republic of Iran, 1997-2002.
We conducted a retrospective review of all cases of Kawasaki disease admitted to the major referral centres in Sari, East Mazandaran from 1 November 1997 to 30 October 2002. Of 29 probable cases, 25 were confirmed, giving an average annual incidence rate of 7.3 per 100 000 in children 0-5 years. The mean age of all cases was 38 months (range: 3.5-80 months). There was a male predominance. The mean time between the onset of illness and diagnosis was 8.2 +/- 3.1 days. Five of the 25 patients had cardiovascular abnormalities before treatment. All patients were treated with intravenous immunoglobulin and 22 (88%) responded to a single dose of treatment and high doses of acetylsalicylic acid; 2 patients needed a second dose of IVIG, and 1 patient required a third. Complete recovery was noted in all patients except for 1, who is under follow-up and treatment.
Saffar
M J
MJ
Department of Paediatrics, Boali Hospital, Mazandaran University of Medical Sciences, Sari, Islamic, Republic of Iran. saffar@softhome.net
Reshidighader
F
F
D017677:Age Distribution; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004452:Echocardiography; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D007492:Iran / Q000453:epidemiology; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D010343:Patient Admission / Q000706:statistics & numerical data; D011159:Population Surveillance; D012017:Referral and Consultation / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012621:Seasons; D017678:Sex Distribution; D013997:Time Factors; D016896:Treatment Outcome; D014504:Urban Health / Q000706:statistics & numerical data*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D001241:Aspirin